Follow RSS for latest reports on this topicStem Cells - Market Research and Reports

Track and monitor developments in stem cell research and commercial development. BioPortfolio markets and sells market research reports on stem cells.

Stem cells have the remarkable potential to develop into many different cell types in the body during early life and growth. In many tissues they serve as an internal repair system, dividing essentially without limit to replenish other cells.  When a stem cell divides, each new cell has the potential either to remain a stem cell or become another type of cell with a more specialized function, such as a muscle cell, a red blood cell, or a brain cell.

Stem cells are distinguished from other cell types by two important characteristics.

1) they are unspecialized cells capable of renewing themselves through cell division, sometimes after long periods of inactivity.

2) under certain physiologic or experimental conditions, they can be induced to become tissue- or organ-specific cells with special functions. In some organs, such as the gut and bone marrow, stem cells regularly divide to repair and replace worn out or damaged tissues. In other organs, however, such as the pancreas and the heart, stem cells only divide under special conditions.

Scientists have primarily worked with two kinds of stem cells: embryonic stem cells and non-embryonic "somatic" or "adult" stem cells.

Scientists discovered ways to derive embryonic stem cells from early mouse embryos nearly 30 years ago, in 1981.  In 2006, researchers identified conditions that would allow some specialized adult cells to be "reprogrammed" genetically to assume a stem cell-like state. This new type of stem cell, called induced pluripotent stem cells (iPSCs).

Given their unique regenerative abilities, stem cells offer new potentials for treating diseases such as diabetes, and heart disease. However, much work remains to be done in the laboratory and the clinic to understand how to use these cells for cell-based therapies to treat disease, which is also referred to as regenerative or reparative medicine.

Adapted from Stem Cell Basics

BioPortfolio's Easy Ordering System

  1. Search for the report you need from our store
  2. Make online payment with our easy checkout process
  3. Receive PDF report via email

Easy Online Payment or Pro Forma Invoice

We accept the following credit cards...

or can supply a pro-forma invoice if required.

Related Reports:

We found over 40 reports that matched your search.

Next 40 Matches >

Refine your search, and find more matches, using the form above.

Global Single Use bioreactor Market Size study, by Product Type, by Type of Cells (Mammalian Cells, Yeast Cells, Bacterial Cells, Other cells), by Technology(Stirred Single-use bioreactors, Single-use bubble column bioreactors, Wave-induced motion single-use bioreactors, Other Technologies), by Application, End-User (Biopharmaceutical Manufacturers, R&D Departments), by and Regional Forecasts 2018

Global Single Use Bioreactor Market to reach USD 4857.4 billion by 2025.Global Single Use Bioreactor Market valued approximately USD 989.7 billion in 2017 is anticipated to grow with a healthy growth rate of more than 22% over the forecast period 2018-2025.Single-use bioreactors are broadly utilized as a part of the field of mammalian cell culture and are currently quickly supplanting regular bior...Read More >>>


Published by: Bizwit Research and Consulting

Prices Starting From:


Published by: The Business Research Company

Prices Starting From:


Published by: MarketsandMarkets

Prices Starting From:


Published by: MarketsandMarkets

Prices Starting From:


Published by: MarketsandMarkets

Prices Starting From:

Additional Searches

You may also like to search separately for: Stem Cells

We Stock...